MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to atyr pharma,...
-$10,791,000
(27.48%↑ Y/Y)
Net loss
attributable to...
-$1,000
(0.00%↑ Y/Y)
Consolidated net loss
-$10,792,000
(27.48%↑ Y/Y)
Total other income
(expense), net
$644,000
(-27.80%↓ Y/Y)
Loss from operations
-$11,436,000
(27.50%↑ Y/Y)
Total operating
expenses
$11,436,000
(-27.50%↓ Y/Y)
Research and development
$7,317,000
(-38.07%↓ Y/Y)
General and
administrative
$4,119,000
(4.04%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)